Skip to main content
Log in

Extracorporeal hydrophobic amino acid adsorbent therapy in rheumatoid arthritis

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

We developed a new adsorbent utilizing hydrophobic amino acids in order to treat severe rheumatoid arthritis patients with extracorporeal adsorption therapy. In in vitro experiment, the new adsorbent selectively removed immune complexes and rheumatoid factors from RA plasma presumably due to hydrophobic adsorption. Six out of elevent patients markedly improved in clinical as well as laboratory parameters of disease activities, particularly in their extra-articular manifestations. We recommend preferential use of this treatment since it can spare the replacement protein solution and is expected to give similar efficacy to simple plasma exchange therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jaffe, I.A. Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor. Ann Rheum Dis 1963, 22, 71–76.

    CAS  PubMed  Google Scholar 

  2. Wallace, J.D., Goldfinger, D., Gatti, R., et al. Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis. Arthritis Rheum 1979, 22, 703–710.

    CAS  PubMed  Google Scholar 

  3. Jones, J.V., Bucknell, R.C., Cumming, R.M., et al. The role of therapeutic plasmapheresis in the rheumatic diseases. J Lab Clin Med 1981, 97, 589–597.

    CAS  PubMed  Google Scholar 

  4. Scott, G.I.D. Baron, P.A., Bothanmley, J.E., et al. Plasma exchange in rheumatoid vasculitis. J Rheumatol 1981, 8, 433–439.

    CAS  PubMed  Google Scholar 

  5. Brubaker, B.D., Winkelstein, A. Plasma exchange in rheumatoid vasculitis. Vox Sang 1981, 41, 295–301.

    CAS  PubMed  Google Scholar 

  6. Wallace, J.D., Goldfinger, D., Lowe, C., et al. A double-blind, controlled study of lymphoplasmapheresis vs sham apheresis in rheumatoid arthritis. N Engl J Med 1982, 307, 1406–1410.

    Google Scholar 

  7. Shumak, K.H., Rock, G.A. Therapeutic plasma exchange. N Engl J Med 1984, 310, 762–770.

    CAS  PubMed  Google Scholar 

  8. Rothwell, R.S., Davis, P., Gordon, P.A., et al. A controlled study of plasma exchange in the treatment of severe rheumatoid arthritis. Arthritis Rheum 1980, 23, 785–790.

    CAS  PubMed  Google Scholar 

  9. Dwosh, I.L., Giles, A.R., Ford, P.M., et al. Plasmapheresis therapy in the treatment of rheumatoid arthritis, a controlled, a double-blind, crossover trial. N Engl J Med 1983, 308, 1124–1129.

    CAS  PubMed  Google Scholar 

  10. Nozaki, Y., Tanford, C. The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions. J Bio Chem 1971, 246, 2211–2217.

    CAS  Google Scholar 

  11. Yoshinoya, S., McDuffy, S., Alarcon-Segovia, D., et al. Detection and partial characterization of immune complexes in patients with RA plus Sjögren's syndrome and with Sjögren syndrome alone. Clin Exp Immunol 1982, 48 (2), 339–347.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, K., Yoshinoya, S., Yoshizawa, H. et al. Extracorporeal hydrophobic amino acid adsorbent therapy in rheumatoid arthritis. Clin Rheumatol 6, 553–563 (1987). https://doi.org/10.1007/BF02330593

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02330593

Key words

Navigation